Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference
Allergan Aesthetics and Allergan, an ABBVie company announced today that scientific and clinical experts in the field of neurotoxins will...
Pfizer’s XALKORI® Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people Pfizer Inc. today announced that the...
Abbott to Launch the NeuroSphere myPath Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Abbott today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient...
BELLUS Health to Present at the Eleventh International Virtual Cough Symposium
BELLUS Health Inc. a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related...
Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma
Harpoon Therapeutics, Inc. a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that the U.S....
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery
Bausch Health Companies Inc. will provide a preliminary update on its fourth-quarter and full-year 2020 financial results and the continued...
Allergan Aesthetics Enters Into Option to Acquire Cypris Medical
Today Allergan Aesthetics, an ABBVie company announced that it has entered into a warrant agreement with Cypris Medical, a privately...